A new class of fluorinated 5-pyrrolidinylsulfonyl isatin caspase inhibitors for PET imaging of apoptosis
dc.contributor.author | Krause-Heuer, AM | en_AU |
dc.contributor.author | Howell, NR | en_AU |
dc.contributor.author | Matesic, L | en_AU |
dc.contributor.author | Dhand, G | en_AU |
dc.contributor.author | Young, EL | en_AU |
dc.contributor.author | Burgess, L | en_AU |
dc.contributor.author | Jiang, CD | en_AU |
dc.contributor.author | Lengkeek, NA | en_AU |
dc.contributor.author | Fookes, CJR | en_AU |
dc.contributor.author | Pham, TQ | en_AU |
dc.contributor.author | Sobrio, F | en_AU |
dc.contributor.author | Greguric, I | en_AU |
dc.contributor.author | Fraser, BH | en_AU |
dc.date.accessioned | 2018-09-19T22:51:46Z | en_AU |
dc.date.available | 2018-09-19T22:51:46Z | en_AU |
dc.date.issued | 2012-11-12 | en_AU |
dc.date.statistics | 2018-09-18 | en_AU |
dc.description.abstract | Thirteen compounds in a new class of fluorinated 5-pyrrolidinylsulfonyl isatin derivatives were synthesised that have potent and selective inhibitory activity against effector caspases-3 and -7. With in vivo animal PET imaging studies of cerebral ischemia being planned, N-benzylation with selected para-substituted benzylic halides allowed systematic variation of lipophilicity (logP 1.94–3.31) without decreasing inhibition potency (IC50). From this series the p-methoxybenzyl analogue was selected for initial ‘proof-of-concept’ [18F]-fluoride radiolabelling which proceeded in good yield and purity with no need for a protection/deprotection strategy. © 2013 Royal Society of Chemistry | en_AU |
dc.identifier.citation | Krause-Heuer, A. M., Howell, N. R., Matesic, L., Dhand, G., Young, E. L., Burgess, L. Jiang, C. D., Lengkeek, N. A., Fookes, C. J. R., Pham, T. Q., Sobrio, F., Greguric, I & Fraser, B. H. (2013). A new class of fluorinated 5-pyrrolidinylsulfonyl isatin caspase inhibitors for PET imaging of apoptosis. MedChemComm, 4(2), 347-352. doi:10.1039/C2MD20249B | en_AU |
dc.identifier.govdoc | 8780 | en_AU |
dc.identifier.issn | 2040-2503 | en_AU |
dc.identifier.issue | 2 | en_AU |
dc.identifier.journaltitle | MedChemComm | en_AU |
dc.identifier.pagination | 347-352 | en_AU |
dc.identifier.uri | https://doi.org/10.1039/C2MD20249B | en_AU |
dc.identifier.uri | http://apo.ansto.gov.au/dspace/handle/10238/9027 | en_AU |
dc.identifier.volume | 4 | en_AU |
dc.language.iso | en | en_AU |
dc.publisher | Royal Society of Chemistry | en_AU |
dc.subject | Indoles | en_AU |
dc.subject | Enzyme inhibitors | en_AU |
dc.subject | Apoptosis | en_AU |
dc.subject | Cell killing | en_AU |
dc.subject | Indoles | en_AU |
dc.subject | In vivo | en_AU |
dc.subject | Fluorine 18 | en_AU |
dc.subject | Positron computed tomography | en_AU |
dc.title | A new class of fluorinated 5-pyrrolidinylsulfonyl isatin caspase inhibitors for PET imaging of apoptosis | en_AU |
dc.type | Journal Article | en_AU |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: